SureTrader Stock Hero Advertisement SureTrader
Home > Boards > Free Zone > Health and Sciences > Biotech Values

Recall Merck also tried to get an "improved

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
genisi Member Profile
Member Level 
Followed By 31
Posts 5,161
Boards Moderated 0
Alias Born 05/24/06
160x600 placeholder
Advertisement
Charter Communications Nearing Deal for Time Warner Cable -- 3rd Update
Charter Communications Inc. is nearing an acquisition of Time Warner Cable Inc. in a roughly $55 billion deal that would vault the cable operator to the ranks of the biggest U.S. broadband and pay-television companies, creating a more potent rival for the likes of Comcast Corp. and DirecTV.
Libor Case Comes to Trial
Spy Agencies Explored Tapping Google, Samsung App Servers
Turkish Car Maker Tofas Says Has Resumed Production After Strike
Crystal Ball: Send Us Your Guess for H-P's Stock Price
GE CEO Open to Intellectual Property Sales to Get Alstom Nod -- Update
Salesforce Revenue Outpaces Wall Street Views -- Update
BlackBerry to Cut Jobs in Device Arm
Vanguard Natural Resources to Buy Eagle Rock Energy Partners
Verizon's AOL Deal Aimed At Video Ads
genisi Member Level  Wednesday, 04/27/11 03:49:51 AM
Re: biomaven0 post# 118902
Post # of 191663 
Recall Merck also tried to get an "improved niacin" by targeting the same receptor with MK-0354, which despite significant decreases in FFAs levels and absence of flushing failed to demonstrate effects on HDL/LDL-Cholesterol and TGs in phase II. Obviously, being a GPR109A receptor agonist isn't all.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist